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Inhibition of Soluble Epoxide Hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis
Supplemental Methods:
S1: The properities of sEHIs
Earlier compounds such as 12-(3-adamantan-1-yl-ureido)-dode -canoic acid (AUDA) has poor metabolic stability, relatively high melting point, and limited solubility in water or even many organic solvents making them difficult to use pharmacologically 1 .
A followed inhibitor termed 1-adamantanyl -3-(5-(2-(2-ethoxyethoxy)ethoxy)pentyl)) urea (AEPU), which had dramatically improved water solubility and a lower melting point facilitating formulation 
trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB)
has better oral bioavailability and metabolic stability than their predecessors, possibly due to greater water solubility and resistance to metabolism 4 .
Following oral administration in the drinking water, a fairly stable blood concentration of t-AUCB is maintained for several days 5 .
Some cautions should be indicated when giving these compounds orally.
Something like, "sEH inhibitors are lipophilic high melting solids. As such they are difficult to formulate. If they fall out of solution and form crystals, their bioavailability decreases dramatically. There are numerous techniques to prepare aqueous solutions for oral administration. It is important that the organic co-solvent is added with stirring to warm water. The drinking water should be checked to insure that the compound has not fallen out of solution. If the water becomes acidic by absorbing CO2 or is kept in the cold, the compound will precipitate rapidly and be difficult to get back into solution.
2
S2: RCT in vivo
In brief, Raw264.7 macrophages were washed twice and incubated with 37.5 μg/mL acetylated LDL (acLDL) and 5 μCi/mL 3 H-cholesterol for 24
hours. Cells were washed, equilibrated, centrifuged and resuspended in DMEM before intraperitoneal injection. The 3 H-cholesterol levels in macrophages were recorded by liquid scintillation counting (LSC). Feces were collected daily, hydrated in a 50% ethanol solution and then homogenized to reach the concentration of 0.114g feces/mL overnight. The fecal homogenate (0.3 mL) was mixed with liquid scintillation fluid (1 mL). The tubes were kept in the dark for 24 hour to reduce chemiluminescence, and then qualified for radioactivity in fecal homogenate via LSC.
S3: Laboratory Methods
Quantitative Real-time PCR analysis
Liver, and adipose tissue were homogenized in Trizol (Invitrogen) and RNA isolated were performed via manufacturer's instructions and quantified by spectrophotometer. RNA (500 ng) was reverse transcribed using an Applied Biosystems High Capacity cDNA archive kit. Quantification of mRNA expressions was performed by SYBR green assay system and ABI 7300 Real 
Western-blot analysis
Tissues were homogenized in RIPA buffer (100 mg/mL). A variety of sEHis were available used in animal models. Increases in oral bioavailability and improved physicochemical properties were obtained with AEPU (A). t-AUCB has better oral bioavailability and metabolic stability than their predecessors and it used in our study (B). AR9276
(1-(1-nicotinoylpiperidin-4-yl)-3-(4-(trifluorometh oxy) phe-nyl) urea) are more potent, selective and orally available s-EH inhibitors(C). AR9276 treatment in drinking water in mice almost completely abolished whole blood sEH activity.
Supplement Figure 1 . Structures of representative sEHIs.
